[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 Aluminum Corporation of China Limited Date April 23, 2018 By About the Company Our contact information of this release is: * Business address: No. 62 North Xizhimen St]
[1 Announcement dated April 20, 2018 in respect of Key Financial and Performance Indicators for the First Quarter of 2018. 2 Announcement dated April 20, 2018 in respect of Operational Statistics for March 2018. build-out the Companys ability to effectively sustain its growth and to achieve or enh]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 Aluminum Corporation of China Limited Date April 23, 2018 By About the Company Our contact information of this release is: * Business address: No. 62 North Xizhimen St]
[1 Announcement dated April 20, 2018 in respect of Key Financial and Performance Indicators for the First Quarter of 2018. 2 Announcement dated April 20, 2018 in respect of Operational Statistics for March 2018. build-out the Companys ability to effectively sustain its growth and to achieve or enh]
[Number Page 1.1 Announcement, dated April 20, 2018 A-1 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansion and capital expenditure plans; • the expected im]
[Number Page 1.1 Announcement, dated April 20, 2018 A-1 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansion and capital expenditure plans; • the expected im]
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, April 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on EX-99.1 2 e]
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, April 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on EX-99.1 2 e]
